Send the following on WhatsApp
Continue to ChatDénosumab, anticorps monoclonal anti-RANKL, à effet anti-ostéoporotique https://www.pharmacorama.com/2006/02/denosumab-anticorps-monoclonal-anti-rankl-effet-anti-osteoporotique/
Dénosumab, anticorps monoclonal anti-RANKL, à effet anti-ostéoporotique https://www.pharmacorama.com/2006/02/denosumab-anticorps-monoclonal-anti-rankl-effet-anti-osteoporotique/